Literature DB >> 11826183

Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring.

Adam Bagg1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11826183      PMCID: PMC1906972          DOI: 10.1016/S1525-1578(10)60675-7

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


× No keyword cloud information.
  72 in total

1.  Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience.

Authors:  D Campana; G A Neale; E Coustan-Smith; C H Pui
Journal:  Leukemia       Date:  2001-02       Impact factor: 11.528

2.  Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.

Authors:  K Dhingra; R Kurzrock; H Kantarjian; R Baine; P S Eastman; S Ku; J U Gutterman; M Talpaz
Journal:  Leukemia       Date:  1992-08       Impact factor: 11.528

3.  Improved results with PCR for chronic myeloid leukaemia.

Authors:  T Hughes; J M Goldman
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

4.  Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.

Authors:  M S Roth; J H Antin; R Ash; V H Terry; M Gotlieb; S M Silver; D Ginsburg
Journal:  Blood       Date:  1992-01-01       Impact factor: 22.113

5.  Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.

Authors:  M Talpaz; H Kantarjian; R Kurzrock; J M Trujillo; J U Gutterman
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

6.  Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

Authors:  P Vigneri; J Y Wang
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

7.  Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.

Authors:  N C Cross; L Feng; A Chase; J Bungey; T P Hughes; J M Goldman
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

8.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Authors:  P M Holland; R D Abramson; R Watson; D H Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients.

Authors:  K Miyamura; T Tahara; M Tanimoto; Y Morishita; K Kawashima; Y Morishima; H Saito; S Tsuzuki; K Takeyama; Y Kodera
Journal:  Blood       Date:  1993-02-15       Impact factor: 22.113

10.  Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse.

Authors:  T P Hughes; G J Morgan; P Martiat; J M Goldman
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

View more
  2 in total

Review 1.  Clinical applications of BCR-ABL molecular testing in acute leukemia.

Authors:  Amgad L Nashed; Kathleen W Rao; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

Review 2.  Molecular genetics of pediatric soft tissue tumors: clinical application.

Authors:  Chung-Che Chang; Vinod B Shidham
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.